Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer

NCT03229187 · clinicaltrials.gov ↗

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms
Cervical Cancer
Uterine Cervical Cancer

Sponsor

Huazhong University of Science and Technology

Collaborators

[object Object]
[object Object]